Patients with positive PD-L1 expression attained an ORR of 43.5%, and patients with TPS ≥ 1% had an ORR of 32.1% versus 0% for those with TPS < 1%, suggesting that tumor response was indeed due to blockade of the PD-1/PD-L1 axis. Here, CD274 is linked to neoplasm.